Delivery Order SPE2DR25D1103-SPE2DR26FE497
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count packages) with a ceiling value of $1,013.34. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. The order is scheduled for completion by December 5, 2025, with fulfillment occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $2,564.77 delivery order by the Defense Logistics Agency on September 8, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 9, 2025. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100, with a contract ceiling value of $2,038.30. This non-competitive delivery order represents a firm fixed-price transaction and is scheduled for completion by December 16, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,052.07. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $1,660.44. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively made. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 9, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ambien CR 6.25 mg tablets (100 count) with a ceiling value of $1,345.73. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for completion by December 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,755.58 to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units. This firm fixed-price, competitively awarded contract is set to be completed by December 22, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,116.22 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and is classified as a child contract under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.40 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100 count) on November 24, 2025, with completion scheduled for November 25, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a ceiling value of $2,094.39. This competitively awarded, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of September 24, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company serves as a major...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FE497Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Ambien CR 6.25 mg tablets (100-count units) with a ceiling value of $1,350.24. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of December 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply an expansive portfolio of pharmaceutical products and medical supplies to support military healthcare systems globally. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the Department of Defense and related federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As a major vendor in the DLA Medical Supply Chain, the company maintains an established track record of fulfilling competitive federal procurement requirements across multiple therapeutic domains, from specialty medications and vaccines to medical devices and diagnostic supplies. The Pharmaceutical Prime Vendor Global Program represents a strategic sourcing approach allowing DLA to leverage multiple contractors across different regions, with AmerisourceBergen positioned as one of the primary suppliers for this essential federal medical logistics function.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/21/25 |